PMID- 37251906
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20230531
IS  - 2405-8440 (Print)
IS  - 2405-8440 (Electronic)
IS  - 2405-8440 (Linking)
VI  - 9
IP  - 5
DP  - 2023 May
TI  - Potential effects of bisphenol A on diabetes mellitus and its chronic 
      complications: A narrative review.
PG  - e16340
LID - 10.1016/j.heliyon.2023.e16340 [doi]
LID - e16340
AB  - Diabetes mellitus (DM) is a metabolic disease caused by multiple factors such as 
      genetics, environment, and lifestyle. Bisphenol A (BPA), as one of the most 
      common endocrine-disrupting chemicals (EDCs), has been strongly implicated in the 
      development of type 2 diabetes mellitus (T2DM). BPA exposure is associated with 
      target organ damage in DM and may exacerbate the progression of some chronic 
      complications of DM. This paper reviews relevant epidemiological, in vivo, and in 
      vitro studies to better understand BPA's potential risk associations and 
      pathological mechanisms in several chronic diabetic complications.
CI  - (c) 2023 The Authors.
FAU - Jiang, Wei
AU  - Jiang W
AD  - Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, 
      China.
FAU - Ding, Kaixi
AU  - Ding K
AD  - Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, 
      China.
FAU - Huang, Wenjie
AU  - Huang W
AD  - Chengdu University of Technology, College of Ecology and Environment, Chengdu, 
      610075, China.
FAU - Xu, Feng
AU  - Xu F
AD  - School of Engineering and Built Environment, Griffith University, Nathan, QLD, 
      4111, Australia.
FAU - Lei, Ming
AU  - Lei M
AD  - Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, 
      China.
FAU - Yue, Rensong
AU  - Yue R
AD  - Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, 
      China.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20230517
PL  - England
TA  - Heliyon
JT  - Heliyon
JID - 101672560
PMC - PMC10213369
OTO - NOTNLM
OT  - Bisphenol A
OT  - Chronic diabetic complications
OT  - Epidemiology
OT  - Harmful effects
OT  - Pathological mechanisms
COIS- The authors declare that they have no known competing financial interests or 
      personal relationships that could have appeared to influence the work reported in 
      this paper.
EDAT- 2023/05/30 13:07
MHDA- 2023/05/30 13:08
PMCR- 2023/05/17
CRDT- 2023/05/30 11:46
PHST- 2022/08/25 00:00 [received]
PHST- 2023/05/10 00:00 [revised]
PHST- 2023/05/12 00:00 [accepted]
PHST- 2023/05/30 13:08 [medline]
PHST- 2023/05/30 13:07 [pubmed]
PHST- 2023/05/30 11:46 [entrez]
PHST- 2023/05/17 00:00 [pmc-release]
AID - S2405-8440(23)03547-8 [pii]
AID - e16340 [pii]
AID - 10.1016/j.heliyon.2023.e16340 [doi]
PST - epublish
SO  - Heliyon. 2023 May 17;9(5):e16340. doi: 10.1016/j.heliyon.2023.e16340. eCollection 
      2023 May.